Yi Qun Wang

Yi Qun Wang

Director/Board Member at MICROPORT NEUROTECH LIMITED

Net worth: - $ as of 2024-04-29

59 year
Consumer Services
Health Technology

Profile

Yi Qun Wang is currently the Director at MicroPort NeuroTech (Shanghai) Co., Ltd.
since 2015 and the Executive Director & Executive Vice President at MicroPort NeuroTech Ltd.
since 2015.
Previously, Mr. Wang served as the Chief Executive Officer & Managing Director at Medinova Global LLC from 2013 to 2015 and as the Senior Manager-Marketing & Principal Engineer at Boston Scientific Corp.
from 1995 to 2013.
Mr. Wang holds an MBA degree from Temple University (Pennsylvania) in 2006, a graduate degree from the University of Florida in 1992, and an undergraduate degree from Beijing University of Chemical Technology in 1986.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-27 0 ( -.--% ) - $ 2024-04-29

Yi Qun Wang active positions

CompaniesPositionStart
MICROPORT NEUROTECH LIMITED Director/Board Member 2020-11-01
MicroPort NeuroTech (Shanghai) Co., Ltd. Director/Board Member 2015-11-30
All active positions of Yi Qun Wang

Former positions of Yi Qun Wang

CompaniesPositionEnd
Medinova Global LLC Chief Executive Officer 2014-12-31
BOSTON SCIENTIFIC CORPORATION Sales & Marketing 2012-12-31
See the detail of Yi Qun Wang's experience

Training of Yi Qun Wang

Temple University (Pennsylvania) Masters Business Admin
University of Florida Graduate Degree
Beijing University of Chemical Technology Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yi Qun Wang's experience

Connections

99

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BOSTON SCIENTIFIC CORPORATION

Health Technology

MICROPORT NEUROTECH LIMITED

Health Technology

Private companies2
MicroPort NeuroTech (Shanghai) Co., Ltd.

Medinova Global LLC

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW